Form 4: Jazz Pharmaceuticals EVP Neena M Patil Sells Shares to Cover Tax Obligations
SEC Form 4
Neena M Patil, EVP & Chief Legal Officer of Jazz Pharmaceuticals, disposed of 4,088 ordinary shares to satisfy tax obligations arising from vesting restricted stock units.
Summary
- Neena M Patil, an Executive Vice President and Chief Legal Officer at Jazz Pharmaceuticals plc, reported a transaction involving the disposal of company shares.
- On March 5, 2025, Patil disposed of 4,088 ordinary shares at a price of $138.95 per share.
- This transaction was executed to cover tax obligations related to the vesting of previously granted restricted stock units.
- Following the transaction, Patil directly owns 47,526 ordinary shares of Jazz Pharmaceuticals.
Sentiment
Score: 5
Explanation: Neutral sentiment as the transaction is related to tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.
Industry Context
This is a routine transaction for executives to cover tax obligations when stock options or restricted stock units vest. It is a common practice and doesn't necessarily indicate a negative outlook on the company.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of transaction: Disposal of ordinary shares. |
| 03/07/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.